Wang et al. reported that CS can significantly inhibit the high expression of P2X7R, and suppress the activation of NLRP3 inflammasome in podocytes, which may be one of the important mechanisms for the therapeutic effects of CS on DN (Wang C. et al., 2018). This evidence concerns the gene NLRP3 and liver dysplastic nodule.